Moderna
MRNA
#1089
Rank
A$29.73 B
Marketcap
A$75.29
Share price
-1.55%
Change (1 day)
38.01%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$49.61 M-25.74%
2025A$66.81 M-57.25%
2024A$0.15 B15.08%
2023A$0.13 B-50.15%
2022A$0.27 B-85.7%
2021A$1.90 B158.2%
2020A$0.73 B369.18%
2019A$0.15 B1011.49%
2018A$14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
A$37.69 MA$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$0.26 BA$0.33 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$0.11 BA$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
N/AA$5.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$0.09 MA$0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$8.14 MA$37.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$4.36 MA$8.39 M๐Ÿ‡บ๐Ÿ‡ธ USA